Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$62.69 - $88.44 $10,155 - $14,327
-162 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$63.15 - $90.42 $10,230 - $14,648
162 New
162 $13,000
Q1 2021

May 06, 2021

SELL
$72.25 - $168.95 $106,279 - $248,525
-1,471 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$125.56 - $178.74 $18,582 - $26,453
-148 Reduced 9.14%
1,471 $251,000
Q3 2020

Nov 04, 2020

SELL
$127.12 - $172.34 $50,212 - $68,074
-395 Reduced 19.61%
1,619 $227,000
Q2 2020

Aug 07, 2020

SELL
$93.0 - $171.7 $58,125 - $107,312
-625 Reduced 23.68%
2,014 $323,000
Q1 2020

May 15, 2020

SELL
$82.38 - $131.64 $51,075 - $81,616
-620 Reduced 19.02%
2,639 $258,000
Q4 2019

Feb 12, 2020

BUY
$76.53 - $135.58 $249,411 - $441,855
3,259 New
3,259 $421,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.9B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.